Max Planck Institute Purchases Automation Technology from Formulatrix
News Jul 21, 2005
According to Formulatrix, the department of Biophysical chemistry has successfully deployed Rock Maker and Rock Imager for automation of protein crystallization.
Martin Kollmar, group leader of Biophysical Chemistry department at MPI said, "We were looking for a software solution that not only allows for designing and tracking of crystallization experiments, but also operates liquid handling and imaging robots.
As far as we know, Rock Maker is the only software on the market that solves this problem. In addition, Formulatrix builds an imaging robot that provides very good pictures of crystallization drops from all kinds of 96-well plates. We are very happy that Formulatrix was able to deliver a customized solution, and that we get immediate support."
Jeremy Stevenson, founder and CEO of Formulatrix stated "We are very pleased to add Max Planck to our growing list of customers, especially as a key reference site for the European market."
Formulatrix specializes in providing technology that automates the protein crystallization process, a key part of structure based drug discovery.
PhoreMost Completes $15M (£11M) Series-A Round to Enter Drug DiscoveryNews
Investment to fund expansion of operations and progression of drug target pipeline.READ MORE
Targeting a Leaky Protein that Causes ParalysisNews
A rare genetic disorder in which people are overcome suddenly with profound muscle weakness is caused by a hole in a membrane protein that allows sodium ions to leak across cell membranes. Compounds containing a chemical group called guanidinium can block the pore created by the mutation and stop the sodium leak without altering the voltage sensor’s ability to function.READ MORE
Computation and Chemistry Combine to Create World-First Auxetic ProteinNews
A team of chemists at the University of California, San Diego (UCSD) has now designed a two-dimensional protein crystal that toggles between states of varying porosity and density. This is a first in biomolecular design that combined experimental studies with computation done on supercomputers. The research, published in April 2018 in Nature Chemistry, could help create new materials for renewable energy, medicine, water purification, and more.
Comments | 0 ADD COMMENT
9th International Conference on Mass Spectrometry and Chromatography
Sep 21 - Sep 22, 2018